Significance of Quantitative Analysis of AML1/ETO Transcripts in Peripheral Blood Stem Cells from t(8;21) Acute Myelogenous Leukemia

Leukemia and Lymphoma

Volumn 25, Issue 42006, 1997, Pages 69-75

  Miyamoto, Toshihiro ^a   Nagafuji, Koji ^a   Harada, Mine ^a   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

AML1 ETO; competitive RT PCR; minimal residual disease; peripheral blood stem cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CHROMOSOME 21Q; CHROMOSOME 8Q; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW; STEM CELL TRANSPLANTATION;

BLOOD CELLS; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 0030903276     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709042497     Document Type: Article

References (37)

1. Kessinger A., Armitage J. O. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211 – 213
2. Lowry P. A., Tabbata I. A. Peripheral haematopoietic stem cell transplantation: current concepts. Experimental Hematology 1992; 20: 937 – 942
3. Korbling M., Fliedner T. M., Holle R., Magrin S., Baumann M., Holdermann E., Eberhardt K. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hematopoietic reconstitution and disease-free survival. Bone Marrow Transplantation 1991; 7: 343 – 349
4. Sanz M. A., De la Rubia J., Sanz G. F., Martin G., Martinez J., Jarque I., Sempere A., Gomis F., Senent L., Soler M. A., Lopez F., Arilla M. J., Carpio N., Guinot M., Palau J., Tudela M., Mary M. L. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: A report from single institution. Journal of Clinical Oncology 1993; 11: 1661 – 1667
5. Gale R. P., Horowitz M. M., Butturini A. Autotransplants in acute leukemia. British Journal of Hematology 1991; 78: 135 – 137
6. Powles R., Mehta J., Singhai S., Horton C., Tait D., Milan S., Pollard C., Lumley H., Matthey F., Shirley J., Williams H., Samaratunga I., Lakhani A., Millar J., Traleaven I. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplantation. 1995; 16: 241 – 247
7. Moss T. J., Sanders D. G., Lasky L. C., Bostrom B. Contamination of peripheral stem cell harvests by circulating neuroblastoma cells. Blood 1990; 76: 1879 – 1883
8. Ross A. A., Cooper B. W., Lazarus H. M., Ciobanu N., Kahn D. G., Tallman M. S. Immunocytologic detection of tumor cells in peripheral blood stem cell collections of breast cancer patients. Breast Cancer Research and Treatment 1991; 19: 161a
9. Sharp J. G., Kessinger A., Vaughan W. P., Mann S., Crouse D. A., Duicke K., Masih A., Weisenburger D. D. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. International Journal of Cell Cloning 1992; 10: 92 – 94
10. Langland K., Craig J. I. O., Parker A. C., Anthony R. S. Molecular determination of tumor contamination in peripheral blood stem cell harvests. Experimental Hematology 1990; 18: 680
11. Nagafuji K., Harada M., Takamatsu Y., Eto T., Teshima T., Kamura T., Okamura T., Hayashi S., Akashi K., Murakawa M., Niho Y. Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase reaction. British Journal of Haematology 1993; 85: 578 – 583
12. Miyamoto T., Nagafuji K., Harada M., Eto T., Fujisaki T., Kubota A., Akashi K., Mizuno S., Takenaka K., Kanaji T., Gondo H., Okamura T., Inaba S., Niho Y. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukemia. British Journal of Haematology 1995; 91: 132 – 138
13. Deisseroth A. B., Zu Z., Claxton D., Hanania E. G., Fu S., Ellerson D., Goldberg L., Thomas M., Janicek K., Anderson W. F., Hester J., Korbling M., Durett A., Moen R., Berenson R., Heimfeld S., Hamer J., Calvert L., Tibbits P., Talpatz M., Kantarjian H., Champlin R., Reading C. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068 – 3076
14. Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J., Ritz J., Nadler L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New England Journal of Medicine 1991; 325: 1525 – 1533
15. Brenner M. K., Rill D. R., Moen R. C., Krance R. C., Mirro J., Anderson W. F., Ihle J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85 – 86
16. Swirsky D. M., Li Y. S., Matthews J. G., Flemans R. J., Rees J. K. H., Hayhoe F. G. J. 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features. British Journal of Haematology 1984; 56: 199 – 213
17. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AMU. Proceedings of National Academy of Science of the United States of America 1991; 88: 10431 – 10434
18. Erickson P., Gao J., Chang K. S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J., Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825 – 1831
19. Meyers S., Downing J. R., Hiebert S. W. Identification of AML-1 and the t(8;21) translocation protein (AML-1/ETO) as sequence specific DNA binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Molecular and Cellular Biology 1992; 13: 6336 – 6345
20. Lo Coco F., Diverio D., Pandolfi P. P., Biondi A., Rossi V., Avvisati G., Rambaldi A., Arcese W., Petti M. C., Meloni G., Mandelli F., Grignani F., Masera G., Barbui T., Pelicci P. G. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet 1992; 340: 1437 – 1438
21. Miller W. H., Jr., Kakizuka A., Frankel S. R., Warrell R. P., Jr., De Blasio A., Levine K., Evans R. M., Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proceedings of National Academy of Science of the United States of America 1992; 89: 2694 – 2698
22. Diverio D., Pandolfi P. P., Biondi A., Avvisati G., Petti M. C., Mandelli F., Pelicci P. G., Lo Coco F. Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 1993; 82: 3556 – 3559
23. Delfau M. H., Kerckaert J. P., D'Hooghe M. C., Fenaux P., Lai J. L., Jouet J. P., Grandchamp B. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990; 4: 1 – 5
24. Hughes T. P., Morgan G. J., Martiat P., Goldman J. M. Detection of residual leukemia after bone marrow transplantation for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874 – 878
25. Lee M. S., Kantarjian H., Talpaz M., Freireich E. J., Deisseroth A., Trujillo J. M., Stass S. A. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood. 1992; 79: 1920 – 1923
26. Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712 – 715
27. Kusec R., Laczika K., Knobl P., Friedl J., Greinix H., Kahls P., Linkesch W., Schwarzinger I., Mitterbauer G., Purtscher B., Haas O. A., Lechner K., Jaeger U. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia. 1994; 8: 735 – 739
28. Chang K. S., Fan Y. H., Staas S. A., Estey E. H., Wang G., Trujillo J. M., Erickson P., Drabkin H. Expression of AML1/ETO fusion transcripts and detection of minimal residual disease in t(8;21 (-positive acute myeloid leukemia. Oncogene. 1993; 8: 983 – 988
29. Maruyama F., Staas S. A., Estey E. H., Cork A., Hirano M., Ino T., Freireich E. J., Yang P., Chang K. S. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 1994; 8: 40 – 45
30. Guerrasaio A., Rosso C. G., Martinelli, Lo Coco F., Pampinella M., Santoro A., Lanza, Allione C. B., Resegotti L., Saglio G. Polyclonal haemopoiesis associated with long-term persistence of the AMLI/ETO transcript in patients with FAB M2 acute myeloid leukaemia in continuous clinical remission. British Journal of Haematology 1995; 90: 364 – 368
31. Cross N. C. P. Quantitative PCR techniques and application. British Journal of Haematology 1995; 89: 693 – 697
32. Shimizu K., Miyoshi H., Kozu T., Nagata J., Enomoto K., Maseki N., Kaneko Y., Ohki M. Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Research. 1992; 52: 6945 – 6948
33. Kozu T., Miyoshi H., Shimizu K., Maseki N., Kaneko Y., Asou H., Kamada N., Ohki M. Junctions of the AML1/MTGH (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood. 1993; 82: 1270 – 1276
34. Gribben J. G., Neuberg D., Barber M., Moore J., Pesek K. W., Freedman A. S., Nadler L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800 – 3807
35. Moss T. J., Cairo M., Santana V. M., Weinthal J., Hurvitz C., Bostrom B. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood. 1994; 83: 3085 – 3089
36. Cross N. C. P., Feng L., Chase A., Bungey J., Hughes T. P., Goldman J. M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929 – 1936
37. Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712 – 715